Response Genetics (RGDX) Reports Q1 Loss of $0.10

Response Genetics (NASDAQ: RGDX) reported Q1 EPS of ($0.10), versus ($0.09) reported last year. Revenue for the quarter came in at $3.8 million, versus $3.9 million reported last year.

For earnings history and earnings-related data on Response Genetics (RGDX) click here.

You May Also Be Interested In

• Nvidia returns as Morgan Stanley’s Top Pick on attractive valuation
• Freeport Q3 2026 copper output meets targets; gold sales deferred
• Corteva Inc. (CTVA) PT Raised to $18 at Morgan Stanley